Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions

Gastric Cancer Metastatic to Liver

Interventions

PROCEDURE

Cryoablation

Cryoablation is performed under US or CT guidance per Investigator decision.

DRUG

Tislelizumab

a PD-1 immune check inhibitor

DRUG

Lenvatinib

Lenvatinib capsules

Trial Locations (2)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER